UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

20/11/2020 20:05

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8BHiyhda-2BoCOnZpto1l2utuychrj-2BBiu37OJmyXv= hpDnBwVvYY-2BbmXbpk3OD8Z-2Fj8c7qof-2FX5erglz-76z_xDPID0vOuylFAU8fv4e60wei4J= xqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj= -2F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu2= 31Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjbSai0jxHlsbJVV-2F0mUQaAerN= eUxyqYv70F-2F-2F6bq-2FIYKMfEPWzygU5FxekESwV2-2BLBoVvY9Jb81T1-2BNFrAfDKjPxUZ= mhH-2FvxQ8swcBSmHTtkJTgBU-2BGoPWEF2OQwfbyedkAW3gT0AQdAE3b5hUd6WaQ-3D ** Disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 20 November 2020 =E2=80=93 20:00 (CET) =E2=80=93 regula= ted information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the = =E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci= ses of stock options by members of its personnel, it has disposed of UCB sh= ares OTC in view of deliveries of these shares to the relevant members of t= he personnel, within the framework of the Long Term Incentive Program of th= e UCB Group, as follows: https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8BHiyhda-2BoCOnZMQdiSJbcht-2BmhmkxTCi2av8hRx= G5xwHnpZfvxLMwxmrzgym2ZvSA0-2FjjRLTZk-2BmisAr9_xDPID0vOuylFAU8fv4e60wei4Jxq= EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2= F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu231= Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjZ5A07B-2F5Bh5VHySTEjCOsdnXbQ= PI-2FzhR-2B-2BkjmV8B30v35Q3Y2eeBP-2FTbwKtxE4sx-2FzQeeUF6egYWZcNzRdE4VBazO9l= tQmKSY8u8ue7PFD5us7sahLYzjqR7t-2BrWxxIX6SDBgFwhqNpmDezi5Gyrkc-3D This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ= yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1= 8dK5MiuQ-3D-3D8Gri_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS= l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3Iu= ncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3U= FjGJqXnj28IM4tUA3hjVmcqz-2Bzes8XU73Rjzj1dbLjQjaAjMgn1ZSIuEZtRF-2BK7UagfztwS= yAJNxwMazlZ7qSN0Tyl0mY21oJX2nAkndBp62p0LWXFovdZbqwoLlU5YMg5Bego1TnJ8f5O-2BC= StV-2B-2Bp6TZU2kMISzoNI2Imd2c-3D . =C2=A0 Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i= n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news GenericFile 201120 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click= ?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8BHiyhda-2= BoCOnZBda4A9grmPlU4FU2f-2BW0ie2XAaO836iBXlvbKQgjP9o-3Dksbt_xDPID0vOuylFAU8f= v4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeo= COG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhX= Z1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjd0QLdeZn7U-2F9Iq= ahUr-2F26B4091s-2FPHkq8rPNrw5thV5ZLQ-2F77-2BV-2BFt4f67hirOvC2GWH0tsMU9HK238= -2F3zbbXjsWr1OFJgozF-2Bms-2BsuClqi39YoUC40T0i-2FbNSa1tBzQGwAFvsDw2PTc-2F5MI= BR0AOw-3D GenericFile 201120 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne= t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B= 8BHiyhda-2BoCOnZ6ewQ989qgUs3cchsj1-2BoxfCTV6uI7UwzkE339sfD7Gk-3DwbZX_xDPID0= vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB5= 2Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6= HIwBi-2BhXZ1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjRs2Qv5= KgIkD5qazPgR11hO9eBbDltoOyOaoExliYwg7SX1fLVcXdka8pJSBZvtkeAgKIn0w6T1xOHMy0O= pSx-2FoNeDtjiK6hqSJvoNPsDlmmsSbRwPWOi3gt54BMzKGXtSihe5GLHU9g6YfXkZ5lWv0-3D = GenericFile 201120 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/= ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8B= Hiyhda-2BoCOnZhWreT9cjMV87e2A9Y-2BGzmJkJtxCwxou19xhQMwKj394-3D3e27_xDPID0vO= uylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Z= lf-2FOeoCOG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HI= wBi-2BhXZ1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjRrjJBo8n= PonxTLm10xsNxYQItPv8v98lxeE6Q7SOmH-2FeyyU65ZyUJSlKg-2BGtU70euM3XL-2BcLEAiBD= 8axVVNrKBJeG9zMAXlZ3SkYX5Vugevz3VTBHKMZd3ybe5AbIaRE12rlWRW9pGOfeVkMDeqlW0-3= D Image Chart 1 Nov 20 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-= 2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek0LDXk2-2B8BHiyhda-2BoCOnZMQdiSJb= cht-2BmhmkxTCi2amJqCY5rOaSy2DXR3frli5E-3Da0H0_xDPID0vOuylFAU8fv4e60wei4JxqE= GBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F= 2X9c9g1waQrs7SsLCPjFrUGj3IuncB9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu231D= bw7rmdKPaKrhuHFUOfTf2oHoK3UFjGJqXnj28IM4tUA3hjR23Nif3lhDYTwwDQN1pKz9oeRQYhM= IpHjdbEayFC0t-2F-2BPizTjxwCNOe7JEtMpWSVIf7uQyAobTvNJVKqBfPcKTHvv86udB8cZeNS= RL27ODaaTHlLfvP5jwE7BMmrcfD-2FzZ5tdq2RmTeuBKc6byT3ZA-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT= UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXIJH-2FOlnLC5slKdvhhl5v4zOx56JZO= QeIGvr32TeU-2FK4vXHWlDMMC6bULw6QHal-2BrrW-2Bu3XWcMn0VJteiSG61SWLK6g8Ys9AWGL= Q3Y2GX2S8-3DWX2T_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0= KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waQrs7SsLCPjFrUGj3Iunc= B9Axhh1sr-2Btk2Uo-2BGi6HIwBi-2BhXZ1wAcKJsu231Dbw7rmdKPaKrhuHFUOfTf2oHoK3UFj= GJqXnj28IM4tUA3hjcRUV3rdvVni-2BgfjYmv70YlNXR7S9EkPw3EkYNYZPBNTqCVF5A1WAGahI= uYqyw9Wkv4Pl6RQYsXBTzyrdV273H30edVAx7maNoxeVS9kJOkKs2cFU-2F-2FfbGHL0NCR7yMW= FQlfjoAYusZnSmVpt-2B6ubzc-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

UCB's latest news

17/04/2024 07:01

UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

UCB's latest news

Other stories